The post Patriots’ Terrell Jennings Ready To Answer In Antonio Gibson’s Absence appeared on BitcoinEthereumNews.com. Since going undrafted out of Florida A&M in 2024, running back Terrell Jennings has spent time between the practice squad and active roster of the New England Patriots. (Photo by M. Anthony Nesmith/Icon Sportswire via Getty Images) Icon Sportswire via Getty Images Three running backs currently reside on the active roster for the New England Patriots. One of whom will soon be placed on injured reserve. Antonio Gibson’s season ended on a kickoff return during the first game of October. After being ruled out with a knee injury against the Buffalo Bills, an MRI confirmed that the veteran sustained a torn ACL. That leaves proven production to replace both on offense and on special teams. It leaves a sophomore in line for a call-up from the practice squad of a 3-2 team. Terrell Jennings is ready to make the most of the difficult situation. “Me and Antonio is actually really close. That’s my locker buddy, as well,” the 24-year-old back told reporters during locker room availability on Wednesday. “He told me, ‘It’s your time, man. Just come on. It’s time to go.’ I took that hard, because that’s my brother. I’m with him every day. To see him go down like that, it hurt me to the core. Like, I would be wrong if I didn’t go out there and do my job to uphold his standard.” Jennings made his way to Gillette Stadium as a tryout at rookie minicamp in 2024. It led to a contract being signed by the undrafted free agent out of Florida A&M, who finished his FCS career with 381 carries for 1,754 yards and 24 touchdowns over 45 appearances. From there, the Rattlers product went on to pace the Patriots in rushing during his first NFL preseason before being waived at the 53-man roster… The post Patriots’ Terrell Jennings Ready To Answer In Antonio Gibson’s Absence appeared on BitcoinEthereumNews.com. Since going undrafted out of Florida A&M in 2024, running back Terrell Jennings has spent time between the practice squad and active roster of the New England Patriots. (Photo by M. Anthony Nesmith/Icon Sportswire via Getty Images) Icon Sportswire via Getty Images Three running backs currently reside on the active roster for the New England Patriots. One of whom will soon be placed on injured reserve. Antonio Gibson’s season ended on a kickoff return during the first game of October. After being ruled out with a knee injury against the Buffalo Bills, an MRI confirmed that the veteran sustained a torn ACL. That leaves proven production to replace both on offense and on special teams. It leaves a sophomore in line for a call-up from the practice squad of a 3-2 team. Terrell Jennings is ready to make the most of the difficult situation. “Me and Antonio is actually really close. That’s my locker buddy, as well,” the 24-year-old back told reporters during locker room availability on Wednesday. “He told me, ‘It’s your time, man. Just come on. It’s time to go.’ I took that hard, because that’s my brother. I’m with him every day. To see him go down like that, it hurt me to the core. Like, I would be wrong if I didn’t go out there and do my job to uphold his standard.” Jennings made his way to Gillette Stadium as a tryout at rookie minicamp in 2024. It led to a contract being signed by the undrafted free agent out of Florida A&M, who finished his FCS career with 381 carries for 1,754 yards and 24 touchdowns over 45 appearances. From there, the Rattlers product went on to pace the Patriots in rushing during his first NFL preseason before being waived at the 53-man roster…

Patriots’ Terrell Jennings Ready To Answer In Antonio Gibson’s Absence

2025/10/10 06:58

Since going undrafted out of Florida A&M in 2024, running back Terrell Jennings has spent time between the practice squad and active roster of the New England Patriots. (Photo by M. Anthony Nesmith/Icon Sportswire via Getty Images)

Icon Sportswire via Getty Images

Three running backs currently reside on the active roster for the New England Patriots. One of whom will soon be placed on injured reserve.

Antonio Gibson’s season ended on a kickoff return during the first game of October. After being ruled out with a knee injury against the Buffalo Bills, an MRI confirmed that the veteran sustained a torn ACL.

That leaves proven production to replace both on offense and on special teams. It leaves a sophomore in line for a call-up from the practice squad of a 3-2 team.

Terrell Jennings is ready to make the most of the difficult situation.

“Me and Antonio is actually really close. That’s my locker buddy, as well,” the 24-year-old back told reporters during locker room availability on Wednesday. “He told me, ‘It’s your time, man. Just come on. It’s time to go.’ I took that hard, because that’s my brother. I’m with him every day. To see him go down like that, it hurt me to the core. Like, I would be wrong if I didn’t go out there and do my job to uphold his standard.”

Jennings made his way to Gillette Stadium as a tryout at rookie minicamp in 2024. It led to a contract being signed by the undrafted free agent out of Florida A&M, who finished his FCS career with 381 carries for 1,754 yards and 24 touchdowns over 45 appearances.

From there, the Rattlers product went on to pace the Patriots in rushing during his first NFL preseason before being waived at the 53-man roster deadline. But upon clearing waivers, New England signed Jennings to the practice squad at its formation.

A standard elevation and reversion followed last fall. By winter, so did a promotion to the active roster.

Jennings finished his rookie campaign having logged three appearances. He rushed for 33 yards across 13 carries, was targeted once in the passing game, and saw 38 snaps on offense to go with 18 snaps on special teams.

“Just downhill physicality, physical runs. That’s what I bring to the table,” said the 6-foot, 217-pound Jennings. “Pass pro, as well. I just try to protect my teammates, protect the quarterback and protect the ball, as well. So, getting downhill, running through and breaking tackles. That’s what I like to bring to the table.”

To begin 2025, Jennings missed time in training camp on the way to going unclaimed and again being retained on the scout team. He is now joined there by reigning All-UFL selection Jashaun Corbin, who worked out and signed on Tuesday.

Both running backs are eligible to be elevated three times before a move the 53-man roster would be required to take the field.

“I’m greatly excited,” Jennings said. “To show the world, show these guys, show my teammates that I’m here to play for them and do it all for my team.”

In the event the elevation route is not taken, an active spot will open once Gibson, who earned AFC Special Teams Player of the Week honors in September, is officially moved to injured reserve. The former Washington Commander’s stay in Foxborough has brought 644 rushing yards, 214 receiving yards and 581 return yards across 22 games. It’s also brought three touchdowns.

Starter Rhamondre Stevenson and rookie No. 38 overall pick TreVeyon Henderson will take the lead for the position moving forward.

“I’ve learned resilience and just next-play mindset, because things happen,” Jennings said of the running back room. “You can’t beat yourself up about it. That’s the biggest thing. We don’t back down at all from no challenge. That’s what I’ve learned from this running back group.”

The New Orleans Saints host Sunday’s 1 p.m. ET kickoff at the Caesars Superdome. Jennings is expected to make the trip through one transaction or another.

“I think he’s a great teammate,” head coach Mike Vrabel said during his midweek press conference. “I think he cares about the team. He’s able to play on special teams. He’s able to play on fourth down. He’s got a toughness to him. I think he’s improved.”

Source: https://www.forbes.com/sites/oliverthomas/2025/10/09/patriots-terrell-jennings-awaits-call-up-in-antonio-gibsons-absence/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

The post New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million  appeared on BitcoinEthereumNews.com. One of the most talked-about ecosystems in the cryptocurrency space is the XRP Ledger (XRPL), and DeXRP, the first Presale on XRPL, recently made headlines for its growth story. Attracting over 9,300 investors globally, the project has now raised over $6.4 million and is rapidly emerging as one of the most viral cryptocurrency launches of 2025. By integrating AMM and Order Book trading with a cutting-edge LP system and an open voting process for holders, DeXRP hopes to establish itself as the preferred trading destination for the XRPL community. What is DeXRP?  As the first decentralized exchange (DEX) based on XRPL, DeXRP is taking center stage as XRP continues to solidify its place in the global market. Massive expectation has been generated by the combination of DeXRP’s ambition for an advanced trading platform and XRPL’s established infrastructure, which is renowned for its quick transactions, cheap fees, and institutional-ready capabilities. In contrast to a lot of speculative presales, DeXRP’s development shows both institutional interest and community-driven momentum. Its early achievement of the $6.4 million milestone demonstrates how rapidly investors are realizing its potential. DeXRP Presale Success More than 9,300 distinct wallets have already joined the DeXRP presale, indicating a high level of interest from around the world. A crucial aspect is highlighted by the volume and variety of participation: DeXRP is not merely a niche project; rather, it is emerging as a major force in the XRPL ecosystem. DeXRP’s recent collaborations with WOW Earn and Micro3, as well as its sponsorship of the WOW Summit in Hong Kong, are also contributing factors to this uptick in investor confidence. These actions are blatant attempts to increase the company’s awareness among institutional players and crypto-native groups. The Forbes article summed it up: DeXRP is embedding credibility where others chase hype, marking it as…
Share
2025/09/18 20:14
Share
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
2025/09/18 05:26
Share